Memberlogin

Tuesday, 05 September 2017 14:37

Intravenous treatment with human recombinant ...

Intravenous treatment with human recombinant ApoA-I Milano reduces beta amyloid cerebral deposition in the APP23-transgenic mouse model of Alzheimer's disease.”

Read More